MetaVia Partners with Syntekabio to Enhance DA-1241 Development with AI Technology MetaVia's collaboration with Syntekabio aims to expand the therapeutic applications of DA-1241, leveraging AI technology for drug discovery and optimization.

MetaVia Partners with Syntekabio to Enhance DA-1241 Development with AI Technology #United_States #Cambridge #MetaVia #DA-1241 #Syntekabio